Open Label

Open-label studies play a critical role in clinical development by allowing both investigators and participants to know which treatment is being administered. These studies provide valuable long-term safety, tolerability, and effectiveness data while supporting patient retention and real-world treatment evaluation across diverse therapeutic areas.

Partner With Us

Studies Conducted

Acute & post-surgical pain focus

0 +

Trial Participants

Enrolled in acute pain studies

0 +

Active Sites

Specialized research locations

Overview

Advancing Clinical Research Through Open-Label Studies

Open-label studies provide essential insights into treatment safety, patient adherence, and long-term outcomes beyond controlled trial settings. These studies often serve as extension trials following randomized controlled studies and help sponsors better understand how therapies perform in real-world clinical environments.

Our experienced research teams support efficient study execution, participant engagement, and comprehensive data collection throughout the study lifecycle.

Conditions Covered

Therapeutic Areas Supported Through Open-Label Research

Our sites have experience supporting open-label studies across a broad range of indications, including:

Psychiatry

CNS Disorders

Behavioral Health

Pain Management

Metabolic Disorders

Neurology

Rare Diseases

Women's Health

Gastroenterology

Inflammatory Conditions

Our Approach

Why Sponsors Choose CenExel for Open Label Studies

Our open-label capabilities go beyond recruitment — providing scientific rigor, efficient study execution, and high-quality data to advance clinical research with confidence.

01

Strong Patient Retention

Dedicated engagement strategies help maintain participant involvement throughout long-term studies.

02

Long-Term Safety Monitoring

Comprehensive safety assessments and follow-up procedures support reliable data collection.

03

Experienced Research Teams

Investigators and coordinators are experienced in managing open-label and extension studies across multiple therapeutic areas.

04

High-Quality Data Collection

Standardized processes ensure consistent and accurate reporting of clinical outcomes.

Phase Coverage

Supported Trial Phases

We support open-label studies across multiple stages of clinical development, including extension and post-marketing research programs.

Active across all phases

Phase I

Phase II

Phase III

Phase IV

Our operational infrastructure enables efficient study startup, participant retention, safety oversight, and regulatory compliance across all study phases.

Open Label Task Force

CenExel's research network supports open-label extension studies with experienced investigators, strong patient retention strategies, and operational excellence. Our teams ensure consistent participant follow-up, safety monitoring, and high-quality data collection throughout long-term treatment evaluations.

Explore task force